Project Details
Description
Genome Engineered Natural Killer Cell Immunotherapy against Human Osteosarcoma
| Status | Active |
|---|---|
| Effective start/end date | 8/16/21 → 8/15/25 |
Funding
- NIH Office of the Director
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.